Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Dvir Shechter"'
Autor:
Dvir Shechter, Michal Harel, Abhishek Mukherjee, Leonel M. Sagredo, David Loven, Elad Prinz, Shimrit Avraham, Veronique Orian-Rousseau, Tamar Geiger, Yuval Shaked, Haguy Wolfenson
Publikováno v:
Cells, Vol 9, Iss 10, p 2269 (2020)
Tumor cell heterogeneity is primarily dictated by mutational changes, sometimes leading to clones that undergo a metastatic switch. However, little is known about tumor heterogeneity following chemotherapy perturbation. Here we studied the possible i
Externí odkaz:
https://doaj.org/article/ad1312aa5d2445d9a9d2390480b8e5c2
Autor:
Ruslana Kotsofruk, Elisabeth G.E. de Vries, Tongwu Zhang, Yuval Shaked, Orit Kaidar-Person, Michael Timaner, Tal Kan, Shahar Daniel, Robert S. Kerbel, Ziv Raviv, A. Nevelsky, Dvir Shechter, Ksenia Magidey
Publikováno v:
Oncogene
ONCOGENE, 39(1), 187-203. Nature Publishing Group
ONCOGENE, 39(1), 187-203. Nature Publishing Group
Radiotherapy induces immune-related responses in cancer patients by various mechanisms. Here, we investigate the immunomodulatory role of tumor-derived microparticles (TMPs)—extracellular vesicles shed from tumor cells—following radiotherapy. We
Publikováno v:
Oncogene
The activating transcription factor 3 (ATF3) and the c-Jun dimerization protein 2 (JDP2) are members of the basic leucine zipper (bZIP) family of transcription factors. These proteins share a high degree of homology and both can activate or repress t
Autor:
Tamar Barenholz-Cohen, Jozafina Haj, Dvir Shechter, Daphne Weihs, Yulia Merkher, Daniela Kirchmeier, Yuval Shaked
Publikováno v:
International journal of cancerREFERENCES. 147(10)
Tumor microenvironment-mechanics greatly affect tumor-cell characteristics such as invasion and proliferation. We and others have previously shown that after chemotherapy, tumor cells shed more extracellular vesicles (EVs), leading to tumor growth an
Autor:
Leonel Munoz Sagredo, Shimrit Avraham, Véronique Orian-Rousseau, Haguy Wolfenson, Abhishek Mukherjee, Tamar Geiger, Dvir Shechter, Yuval Shaked, Michal Harel, Elad Prinz, David Loven
Publikováno v:
Cells
Cells, Vol 9, Iss 2269, p 2269 (2020)
Volume 9
Issue 10
Cells, 9 (10), 2269
Cells, Vol 9, Iss 2269, p 2269 (2020)
Volume 9
Issue 10
Cells, 9 (10), 2269
Tumor cell heterogeneity is primarily dictated by mutational changes, sometimes leading to clones that undergo a metastatic switch. However, little is known about tumor heterogeneity following chemotherapy perturbation. Here we studied the possible i
Autor:
Dror Alishekevitz, Sebastien Benzekry, Madeleine Benguigui, Yuval Shaked, Michael Timaner, Ziv Raviv, Dvir Shechter
Publikováno v:
Oncotarget
Oncotarget, Impact journals, 2017, 9 (2), pp.2574-2590. ⟨10.18632/oncotarget.23514⟩
Oncotarget, 2017, 9 (2), pp.2574-2590. ⟨10.18632/oncotarget.23514⟩
Oncotarget, Impact journals, 2017, 9 (2), pp.2574-2590. ⟨10.18632/oncotarget.23514⟩
Oncotarget, 2017, 9 (2), pp.2574-2590. ⟨10.18632/oncotarget.23514⟩
International audience; It has recently been suggested that pro-tumorigenic host-mediated processes induced in response to chemotherapy counteract the anti-tumor activity of therapy, and thereby decrease net therapeutic outcome. Here we use experimen
Autor:
Yuval Shaked, Iris S. Weitz, Ziv Raviv, Dvir Shechter, Michael Timaner, Haim Azhari, Or Perlman, Madeleine Benguigui, Sarit Sivan, Tal Kan
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
Cancer stem cells, also termed tumor initiating cells (TICs), are a rare population of cells within the tumor mass which initiate tumor growth and metastasis. In pancreatic cancer, TICs significantly contribute to tumor re-growth after therapy, due t
Publikováno v:
Lancet (London, England). 387(10016)
340 www.thelancet.com Vol 387 January 23, 2016 The third approach is to focus on geriatric medicine: the population of elderly people is growing worldwide, and these elderly patients need specialised care. Moreover, a change of mindset is needed, fro